InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-06-04 | Kelly Louise Morrison(D-MN03) | house | Sale | $1,001 - $15,000 |
| 2025-04-28 | Kelly Louise Morrison(D-MN03) | house | Sale | $1,001 - $15,000 |
| 2025-01-13 | Rob Bresnahan(R-PA08) | house | Sale | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net revenue | $641.4M+9.8% | $584.1M+17.3% | $498.0M+24.2% | $400.8M+7.3% | $373.6M |
| Cost of sales (exclusive of amortization shown separately below) | $195.0M+2.6% | $190.2M+9.3% | $174.0M+17.0% | $148.7M+9.9% | $135.3M |
| Amortization of acquired intangible assets | $25.5M-7.2% | $27.4M+9.5% | $25.1M-29.5% | $35.5M-11.6% | $40.2M |
| Total cost of sales | $2.09B+3.0% | $2.03B+8.7% | $1.87B+20.2% | $1.55B+14.4% | $1.36B |
| Gross profit | $3.05B+15.1% | $2.66B+12.7% | $2.36B+16.4% | $2.02B+10.1% | $1.84B |
| Selling, general, and administrative | $991.0M+8.1% | $917.1M+4.9% | $874.0M+18.5% | $737.5M+10.0% | $670.4M |
| Research and development | $331.3M+7.7% | $307.5M+6.9% | $287.6M+13.4% | $253.6M+12.6% | $225.3M |
| Amortization of acquired intangible assets | $25.5M-7.2% | $27.4M+9.5% | $25.1M-29.5% | $35.5M-11.6% | $40.2M |
| Restructuring expenses (note 17) | $0-100.0% | $64.2M+599.9% | $9.2M | — | — |
| Acquisition related expenses | $2.0M | $0-100.0% | $10.9M+487.4% | $1.9M | $0 |
| Total operating expenses | $1.37B+2.6% | $1.34B+9.1% | $1.22B+19.5% | $1.02B+9.5% | $935.4M |
| Income from operations | $1.69B+27.7% | $1.32B+16.6% | $1.13B+13.2% | $1.00B+10.7% | $903.7M |
| Interest income (expense), net | $4.1M+109.0% | -$45.7M+3.5% | -$47.4M | — | — |
| Gain (loss) attributable to equity method investments (note 6) | $3.6M+297.2% | -$1.8M+74.6% | -$7.3M | — | — |
| Gain (loss) on equity investments (note 6) | -$10.3M-154.6% | -$4.0M-140.8% | $9.9M | — | — |
| Gain on insurance recoveries | $0 | $0-100.0% | $20.2M | $0 | $0 |
| Other, net | -$5.3M-50.4% | -$3.5M+38.8% | -$5.7M-278.7% | $3.2M+962.1% | $301K |
| Total other income (loss), net | -$7.8M+85.8% | -$55.1M-82.4% | -$30.2M+24.1% | -$39.8M-98.9% | -$20.0M |
| Income before income taxes | $1.68B+32.6% | $1.26B+14.8% | $1.10B+14.7% | $960.5M+8.7% | $883.7M |
| Income taxes (note 12) | $276.8M+13.5% | $243.8M+19.5% | $204.1M+12.7% | $181.0M-55.8% | $409.2M |
| Net income | $1.40B+37.2% | $1.02B+13.7% | $897.6M+15.2% | $779.4M+64.3% | $474.5M |
| Basic earnings per share (note 11) (in dollars per share) | $10K+37.6% | $7K+13.4% | $6K+14.6% | $5K+63.3% | $3K |
| Diluted earnings per share (note 11) (in dollars per share) | $10K+37.4% | $7K+13.6% | $6K+14.9% | $5K+63.6% | $3K |
| Dividend declared per share (in dollars per share) | $2K+10.4% | $2K+9.1% | $2K+4.8% | $2K+7.7% | $2K |
| Basic shares outstanding (000's) (in shares) | $146.7M-0.2% | $147.0M+0.2% | $146.8M+0.5% | $146.1M+0.5% | $145.3M |
| Diluted shares outstanding (000's) (in shares) | $147.3M-0.1% | $147.6M+0.1% | $147.5M+0.3% | $147.0M+0.4% | $146.5M |
| Sleep and Breathing Health | |||||
| Net revenue | $641.4M+9.8% | $584.1M+17.3% | $498.0M+24.2% | $400.8M+7.3% | $373.6M |
| Cost of sales (exclusive of amortization shown separately below) | $195.0M+2.6% | $190.2M+9.3% | $174.0M+17.0% | $148.7M+9.9% | $135.3M |
| Amortization of acquired intangible assets | $25.5M-7.2% | $27.4M+9.5% | $25.1M-29.5% | $35.5M-11.6% | $40.2M |
| Residential Care Software | |||||
| Net revenue | $641.4M+9.8% | $584.1M+17.3% | $498.0M+24.2% | $400.8M+7.3% | $373.6M |
| Cost of sales (exclusive of amortization shown separately below) | $195.0M+2.6% | $190.2M+9.3% | $174.0M+17.0% | $148.7M+9.9% | $135.3M |
| Amortization of acquired intangible assets | $25.5M-7.2% | $27.4M+9.5% | $25.1M-29.5% | $35.5M-11.6% | $40.2M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.